- call +1-201-465-4211
- email sales@mrinsights.biz
Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).
Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
Scope of the Report:
The market is highly concentrated, with high technical and professional level. Key vendors in this market are Mallinckrodt, Praxair and Air Liquide, they are taking up to 91.19% market share in 2017. Inhaled Nitric Oxide types commonly used in this market are 800 ppm and 100 ppm, small players tend to produce lower purity products, such as 1000 ppm or so.
According to the research, North America and Europe comprised the biggest consumption areas. Other markets like Japan and China are growing relatively slow.
Though the gross margin is high, but with complex production process and acquisition between enterprises, we tend to believe that this market is going to keep the monopoly status in the forecast period.
The worldwide market for Inhaled Nitric Oxide is expected to grow at a CAGR of roughly 7.9% over the next five years, will reach 1240 million US$ in 2024, from 780 million US$ in 2019, according to a new study.
This report focuses on the Inhaled Nitric Oxide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Mallinckrodt
Praxair
Air Liquide
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
99.92% Purity
99.99% Purity
Other
Market Segment by Applications, can be divided into
ARDS
PPHN
Other Diseases
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inhaled Nitric Oxide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Inhaled Nitric Oxide, with price, sales, revenue and global market share of Inhaled Nitric Oxide in 2017 and 2018.
Chapter 3, the Inhaled Nitric Oxide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inhaled Nitric Oxide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Inhaled Nitric Oxide market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Inhaled Nitric Oxide sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Inhaled Nitric Oxide Introduction
1.2 Market Analysis by Type
1.2.1 99.92% Purity
1.2.2 99.99% Purity
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 ARDS
1.3.2 PPHN
1.3.3 Other Diseases
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Mallinckrodt
2.1.1 Business Overview
2.1.2 Inhaled Nitric Oxide Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Mallinckrodt Inhaled Nitric Oxide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Praxair
2.2.1 Business Overview
2.2.2 Inhaled Nitric Oxide Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Praxair Inhaled Nitric Oxide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Air Liquide
2.3.1 Business Overview
2.3.2 Inhaled Nitric Oxide Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Air Liquide Inhaled Nitric Oxide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Inhaled Nitric Oxide Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Inhaled Nitric Oxide Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Inhaled Nitric Oxide Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Inhaled Nitric Oxide Manufacturer Market Share in 2018
3.3.2 Top 6 Inhaled Nitric Oxide Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Inhaled Nitric Oxide Market Analysis by Regions
4.1 Global Inhaled Nitric Oxide Sales, Revenue and Market Share by Regions
4.1.1 Global Inhaled Nitric Oxide Sales and Market Share by Regions (2014-2019)
4.1.2 Global Inhaled Nitric Oxide Revenue and Market Share by Regions (2014-2019)
4.2 North America Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
4.3 Europe Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
4.5 South America Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
5 North America Inhaled Nitric Oxide by Country
5.1 North America Inhaled Nitric Oxide Sales, Revenue and Market Share by Country
5.1.1 North America Inhaled Nitric Oxide Sales and Market Share by Country (2014-2019)
5.1.2 North America Inhaled Nitric Oxide Revenue and Market Share by Country (2014-2019)
5.2 United States Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
5.3 Canada Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
5.4 Mexico Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
6 Europe Inhaled Nitric Oxide by Country
6.1 Europe Inhaled Nitric Oxide Sales, Revenue and Market Share by Country
6.1.1 Europe Inhaled Nitric Oxide Sales and Market Share by Country (2014-2019)
6.1.2 Europe Inhaled Nitric Oxide Revenue and Market Share by Country (2014-2019)
6.2 Germany Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
6.3 UK Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
6.4 France Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
6.5 Russia Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
6.6 Italy Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
7 Asia-Pacific Inhaled Nitric Oxide by Country
7.1 Asia-Pacific Inhaled Nitric Oxide Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Inhaled Nitric Oxide Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Inhaled Nitric Oxide Revenue and Market Share by Country (2014-2019)
7.2 China Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
7.3 Japan Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
7.4 Korea Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
7.5 India Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
8 South America Inhaled Nitric Oxide by Country
8.1 South America Inhaled Nitric Oxide Sales, Revenue and Market Share by Country
8.1.1 South America Inhaled Nitric Oxide Sales and Market Share by Country (2014-2019)
8.1.2 South America Inhaled Nitric Oxide Revenue and Market Share by Country (2014-2019)
8.2 Brazil Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
8.3 Argentina Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
8.4 Colombia Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
9 Middle East and Africa Inhaled Nitric Oxide by Countries
9.1 Middle East and Africa Inhaled Nitric Oxide Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Inhaled Nitric Oxide Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Inhaled Nitric Oxide Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
9.3 Turkey Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
9.4 Egypt Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
9.5 Nigeria Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
9.6 South Africa Inhaled Nitric Oxide Sales and Growth Rate (2014-2019)
10 Global Inhaled Nitric Oxide Market Segment by Type
10.1 Global Inhaled Nitric Oxide Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Inhaled Nitric Oxide Sales and Market Share by Type (2014-2019)
10.1.2 Global Inhaled Nitric Oxide Revenue and Market Share by Type (2014-2019)
10.2 99.92% Purity Sales Growth and Price
10.2.1 Global 99.92% Purity Sales Growth (2014-2019)
10.2.2 Global 99.92% Purity Price (2014-2019)
10.3 99.99% Purity Sales Growth and Price
10.3.1 Global 99.99% Purity Sales Growth (2014-2019)
10.3.2 Global 99.99% Purity Price (2014-2019)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2014-2019)
10.4.2 Global Other Price (2014-2019)
11 Global Inhaled Nitric Oxide Market Segment by Application
11.1 Global Inhaled Nitric Oxide Sales Market Share by Application (2014-2019)
11.2 ARDS Sales Growth (2014-2019)
11.3 PPHN Sales Growth (2014-2019)
11.4 Other Diseases Sales Growth (2014-2019)
12 Inhaled Nitric Oxide Market Forecast (2019-2024)
12.1 Global Inhaled Nitric Oxide Sales, Revenue and Growth Rate (2019-2024)
12.2 Inhaled Nitric Oxide Market Forecast by Regions (2019-2024)
12.2.1 North America Inhaled Nitric Oxide Market Forecast (2019-2024)
12.2.2 Europe Inhaled Nitric Oxide Market Forecast (2019-2024)
12.2.3 Asia-Pacific Inhaled Nitric Oxide Market Forecast (2019-2024)
12.2.4 South America Inhaled Nitric Oxide Market Forecast (2019-2024)
12.2.5 Middle East and Africa Inhaled Nitric Oxide Market Forecast (2019-2024)
12.3 Inhaled Nitric Oxide Market Forecast by Type (2019-2024)
12.3.1 Global Inhaled Nitric Oxide Sales Forecast by Type (2019-2024)
12.3.2 Global Inhaled Nitric Oxide Market Share Forecast by Type (2019-2024)
12.4 Inhaled Nitric Oxide Market Forecast by Application (2019-2024)
12.4.1 Global Inhaled Nitric Oxide Sales Forecast by Application (2019-2024)
12.4.2 Global Inhaled Nitric Oxide Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Inhaled Nitric Oxide Picture
Table Product Specifications of Inhaled Nitric Oxide
Figure Global Sales Market Share of Inhaled Nitric Oxide by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
